These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23678261)

  • 1. An Angiotensin receptor blocker prevents arrhythmogenic left atrial remodeling in a rat post myocardial infarction induced heart failure model.
    Kim HS; No CW; Goo SH; Cha TJ
    J Korean Med Sci; 2013 May; 28(5):700-8. PubMed ID: 23678261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin attenuates the oxidative stress, endothelial thrombogenicity and the inducibility of atrial fibrillation in a rat model of ischemic heart failure.
    Cho KI; Koo SH; Cha TJ; Heo JH; Kim HS; Jo GB; Lee JW
    Int J Mol Sci; 2014 Aug; 15(8):14803-18. PubMed ID: 25153633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction.
    Babick A; Chapman D; Zieroth S; Elimban V; Dhalla NS
    J Cell Mol Med; 2012 Dec; 16(12):2958-67. PubMed ID: 22947202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Renal Denervation on Atrial Arrhythmogenic Substrate in Ischemic Model of Heart Failure.
    Yamada S; Fong MC; Hsiao YW; Chang SL; Tsai YN; Lo LW; Chao TF; Lin YJ; Hu YF; Chung FP; Liao JN; Chang YT; Li HY; Higa S; Chen SA
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danqi soft caspule prevents atrial fibrillation by ameliorating left atrial remodeling through inhibiting cardiac fibroblasts differentiation and function.
    Ma J; Ren M; Li J; Zheng C; Chen Q; Ma S
    Phytomedicine; 2022 Jul; 101():154134. PubMed ID: 35525237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.
    Cardin S; Guasch E; Luo X; Naud P; Le Quang K; Shi Y; Tardif JC; Comtois P; Nattel S
    Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):1027-35. PubMed ID: 22923342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shengmai San-derived herbal prevents the development of a vulnerable substrate for atrial fibrillation in a rat model of ischemic heart failure.
    Ma J; Ma S; Yin C; Wu H
    Biomed Pharmacother; 2018 Apr; 100():156-167. PubMed ID: 29428663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction.
    Ju H; Zhao S; Jassal DS; Dixon IM
    Cardiovasc Res; 1997 Aug; 35(2):223-32. PubMed ID: 9349385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart.
    De Carvalho Frimm C; Sun Y; Weber KT
    J Lab Clin Med; 1997 Apr; 129(4):439-46. PubMed ID: 9104887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin Alleviates Atrial Inflammation, Remodeling, and Vulnerability to Atrial Fibrillation after Myocardial Infarction.
    Liu L; Gan S; Li B; Ge X; Yu H; Zhou H
    Int Heart J; 2019 Nov; 60(6):1398-1406. PubMed ID: 31666455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic catestatin treatment reduces atrial fibrillation susceptibility via improving calcium handling in post-infarction heart failure rats.
    Yan M; Liu T; Zhong P; Xiong F; Cui B; Wu J; Wu G
    Peptides; 2023 Jan; 159():170904. PubMed ID: 36375660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats.
    Jain M; Liao R; Ngoy S; Whittaker P; Apstein CS; Eberli FR
    Cardiovasc Res; 2000 Apr; 46(1):66-72. PubMed ID: 10727654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive imaging of angiotensin receptors after myocardial infarction.
    Verjans JW; Lovhaug D; Narula N; Petrov AD; Indrevoll B; Bjurgert E; Krasieva TB; Petersen LB; Kindberg GM; Solbakken M; Cuthbertson A; Vannan MA; Reutelingsperger CP; Tromberg BJ; Hofstra L; Narula J
    JACC Cardiovasc Imaging; 2008 May; 1(3):354-62. PubMed ID: 19356449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model.
    Zhang Y; Dedkov EI; Lee B; Li Y; Pun K; Gerdes AM
    J Card Fail; 2014 Dec; 20(12):1012-9. PubMed ID: 25305503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.
    Liu M; Li W; Wang H; Yin L; Ye B; Tang Y; Huang C
    J Am Heart Assoc; 2019 Nov; 8(21):e013133. PubMed ID: 31623508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor binding following myocardial infarction in the rat.
    Sun Y; Weber KT
    Cardiovasc Res; 1994 Nov; 28(11):1623-8. PubMed ID: 7842454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of renal impairment by angiotensin II type 1 receptor blocker in rats with post-infarction heart failure.
    Wen Z; Cai M; Mai Z; Chen Y; Geng D; Wang J
    Ren Fail; 2013; 35(5):766-75. PubMed ID: 23560762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure.
    Ma J; Yin C; Ma S; Qiu H; Zheng C; Chen Q; Ding C; Lv W
    Drug Des Devel Ther; 2018; 12():3407-3418. PubMed ID: 30349194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.